Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    Why did this record match?
    Device Name :

    Powder Free Nitrile Examination Glove, Pink Colored, Non-Sterile, Tested for Use with Chemotherapy Drugs

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner.

    These gloves were tested for use with chemotherapy drugs and Fentanyl Citrate as per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

    Device Description

    Powder Free Nitrile Examination Glove, Pink Colored, Non-Sterile, Tested for Use with Chemotherapy Drugs and Fentanyl Citrate; Powder Free Nitrile Examination Glove, Orange Colored, Non-Sterile, Tested for Use with Chemotherapy Drugs and Fentanyl Citrate: Powder Free Nitrile Examination Glove, Blue Colored, Non-Sterile, Low Dermatitis Potential, Tested for Use with Chemotherapy Drugs and Fentanyl Citrate: Powder Free Nitrile Examination Glove, Black Colored, Non-Sterile, Low Dermatitis Potential, Tested for Use with Chemotherapy Drugs and Fentanyl Citrate.

    AI/ML Overview

    This document is a 510(k) premarket notification decision letter from the FDA for several types of nitrile examination gloves. It acknowledges the substantial equivalence of the gloves to legally marketed predicate devices.

    The acceptance criteria and device performance are related to the gloves' resistance to permeation by chemotherapy drugs and opioid drugs, specifically Fentanyl Citrate and Xylazine HCl. The study conducted appears to be ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

    1. Table of Acceptance Criteria and Reported Device Performance:

    The document doesn't explicitly state "acceptance criteria" as a pass/fail threshold. Instead, it reports the "Minimum Breakthrough Detection Time in Minutes" for various drugs. For the purpose of this analysis, we can infer that a higher breakthrough time (ideally ">240 minutes") is the desired performance. The document explicitly highlights cases where performance is lower than presumably desired.

    Chemotherapy Drug and ConcentrationMinimum Breakthrough Detection Time (Minutes) - Acceptance (Inferred)Pink Gloves PerformanceOrange Gloves PerformanceBlue Gloves PerformanceBlack Gloves Performance
    Carmustine (BCNU) (3.3 mg/ml)High as possible, ideally >240. (Warning: Do Not Use)12.411.710.114.4
    Cisplatin (1.0 mg/ml)>240 minutes>240>240>240>240
    Cyclophosphamide (Cytoxan) (20.0 mg/ml)>240 minutes>240>240>240>240
    Cytarabine (100 mg/ml)>240 minutes>240Not tested>240>240
    Dacarbazine (DTIC) (10.0 mg/ml)>240 minutes>240>240>240>240
    Doxorubicin Hydrochloride (2.0 mg/ml)>240 minutes>240>240>240>240
    Etoposide (20.0 mg/ml)>240 minutes>240>240>240>240
    Fluorouracil (50.0 mg/ml)>240 minutes>240>240>240>240
    Ifosfamide (50.0 mg/ml)>240 minutes>240Not Tested>240>240
    Methotrexate (25.0 mg/ml)>240 minutes>240Not Tested>240>240
    Mitomycin C (0.5 mg/ml)>240 minutes>240Not Tested>240>240
    Mitoxantrone (2.0 mg/ml)>240 minutes>240Not Tested>240>240
    Paclitaxel (Taxol) (6.0 mg/ml)>240 minutes>240>240>240>240
    Thiotepa (10.0 mg/ml)High as possible, ideally >240. (Warning: Do Not Use)43.143.230.229.2
    Vincristine Sulfate (1.0 mg/ml)>240 minutes>240Not Tested>240>240
    Opioid Drugs
    Fentanyl Citrate Injection (100 mcg/2ml)>240 minutes>240>240>240>240
    Xylazine HCl (100 mg/ml)>240 minutesNot Tested>240>240>240
    Simulated Gastric Acid>240 minutes>240>240>240>240

    Note: For Carmustine (BCNU) and Thiotepa, the warning "Do Not Use with Carmustine (BCNU) and Thiotepa" implies that the reported breakthrough times are considered insufficient for safe use, despite meeting some base level of detection. Thus, the implicit acceptance criterion for these specific drugs is to not use the gloves. For all other drugs where ">240" is reported, this indicates the gloves met or exceeded the 4-hour test duration without breakthrough.

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):

    The document does not explicitly state the sample size (number of gloves or trials) used for the permeation tests. It indicates the testing was "as per ASTM D6978-05 (Reapproved 2019) Standard Practice." This ASTM standard would specify the required sample size and methodology.
    The data provenance is not explicitly stated in terms of country of origin but is presented as results from a technical study. This would be a prospective test, as the gloves were submitted for testing to demonstrate compliance.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    This type of testing (chemical permeation) does not typically involve human experts establishing ground truth in the way medical imaging or clinical diagnoses do. The "ground truth" is established by the specified ASTM D6978-05 standard methodology, which is an objective chemical permeation test using analytical equipment.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

    Not applicable. Chemical permeation testing is a laboratory-based, objective measurement, not subject to subjective adjudication by human readers/experts.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    Not applicable. This is a technical performance test for medical gloves, not a study involving human readers or AI in diagnostic interpretation.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

    Not applicable. This is not an algorithm or AI product.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

    The ground truth is based on objective chemical permeation measurements performed according to ASTM D6978-05 (Reapproved 2019) Standard Practice. This standard defines the method for detecting the breakthrough of specific chemicals through a material.

    8. The sample size for the training set:

    Not applicable. This is not a machine learning or AI-based device, so there is no "training set."

    9. How the ground truth for the training set was established:

    Not applicable for the same reason as point 8.

    Ask a Question

    Ask a specific question about this device

    Why did this record match?
    Device Name :

    Nitrile Examination Glove, Pink Color; Nitrile Examination Glove, Black Color, Nitrile Examination Glove

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The nitrile examination glove is intended to be worn on the hands of examiner's to prevent contamination between patient and examiner. This is a single-use, powder-free, non-sterile device.

    Device Description

    The propose devices is powder free nitrile patient examination gloves, provided as non-sterile and disposable device. The proposed devices are provided with white, black and pink color. There are six sizes, extra-small, medium, large and extra-large, extra extra-large for optional.

    AI/ML Overview

    This is a 510(k) summary for a medical device (Nitrile Examination Gloves), not for an AI/ML powered device, therefore, the requested information elements related to AI/ML device studies (such as sample size for test set, data provenance, number of experts for ground truth, adjudication method, MRMC study, standalone performance, training set sample size, and ground truth establishment for training set) are not applicable.

    The document describes non-clinical testing performed to demonstrate substantial equivalence to a predicate device.

    Here's the table of acceptance criteria and reported device performance based on the provided document:

    Acceptance Criteria and Reported Device Performance

    Test MethodPurposeAcceptance CriteriaReported Device PerformanceResult
    ASTM D6319 - Physical Dimensions Test
    Length (XS)$\ge$ 220 mm226 mmPass
    Width (XS)70 ± 10 mm73 mmPass
    Length (S)$\ge$ 220 mm225 mmPass
    Width (S)80 ± 10 mm85 mmPass
    Length (M)$\ge$ 230 mm235 mmPass
    Width (M)95 ± 10 mm98 mmPass
    Length (L)$\ge$ 230 mm234 mmPass
    Width (L)110 ± 10 mm115 mmPass
    Length (XL)$\ge$ 230 mm235 mmPass
    Width (XL)120 ± 10 mm123 mmPass
    Length (XXL)$\ge$ 230 mm235 mmPass
    Width (XXL)$\ge$ 120 mm124 mmPass
    Thickness
    Finger Thickness$\ge$ 0.08 mmX-Small: 0.104 mm; Small: 0.106 mm; Medium: 0.104 mm; Large: 0.105 mm; X-Large: 0.106 mm; XX-Large: 0.105 mmPass
    Palm Thickness$\ge$ 0.05 mmX-Small: 0.059 mm; Small: 0.060 mm; Medium: 0.060 mm; Large: 0.062 mm; X-Large: 0.061 mm; XX-Large: 0.058 mmPass
    Physical Properties (Before Aging)
    Tensile Strength$\ge$ 14 MPaLot1: 17.6 MPa; Lot2: 18.5 MPa; Lot3: 18.2 MPaPass
    Ultimate Elongation$\ge$ 500%Lot1: 552%; Lot2: 573%; Lot3: 583%Pass
    Physical Properties (After Aging)
    Tensile Strength$\ge$ 14 MPaLot1: 19.8 MPa; Lot2: 20.3 MPa; Lot3: 20.1 MPaPass
    Ultimate Elongation$\ge$ 500%Lot1: 521%; Lot2: 518%; Lot3: 526%Pass
    ASTM D5151 - Freedom from PinholesFreedom from pinholesMeet the requirements of ASTM D5151 Test for AQL 2.5Lot1: $\le$ AQL 2.5; Lot2: $\le$ AQL 2.5; Lot3: $\le$ AQL 2.5Pass
    ASTM D6124 - Powder ResiduePowder Residue$\le$ 2.0 mgLot1: 1.2 mg; Lot2: 1.5 mg; Lot3: 1.2 mgPass
    ISO 10993-10 - IrritationTo determine if the finished device material is an irritantNon-irritatingUnder the conditions of the study, not an irritantPass
    ISO 10993-10 - SensitizationTo determine if the finished device material is a sensitizerNon-sensitizingUnder conditions of the study, not a sensitizerPass
    ISO 10993-11 - Systemic ToxicityTo determine if the finished device material extracts pose a systemic toxicity concernNon-acute systemic toxicityUnder conditions of the study, did not show acute systemic toxicity in vivoPass

    Study Details

    1. Sample size used for the test set and the data provenance: Not applicable. These are non-clinical bench tests on physical products, not an AI/ML test set. The tests were performed on "Lots" of the gloves (Lot1, Lot2, Lot3). The specific sample size for each test within these lots is not specified in this document but implied to be sufficient for meeting the ASTM/ISO standards. The data provenance is from non-clinical testing of the manufacturing output.
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable, as these are objective physical and chemical tests, not requiring expert ground truth in the context of AI/ML evaluation.
    3. Adjudication method for the test set: Not applicable. The results are based on objective measurements against defined standards.
    4. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This concerns a physical medical device (gloves), not an AI/ML powered device.
    5. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable. This concerns a physical medical device (gloves), not an AI/ML powered device.
    6. The type of ground truth used: For physical/chemical properties (e.g., length, thickness, tensile strength, freedom from pinholes, powder residue), the "ground truth" is the quantitative measurement obtained through standardized test methods (ASTM and ISO standards) and compared against pre-defined numerical or qualitative acceptance criteria. For biocompatibility tests (irritation, sensitization, systemic toxicity), the ground truth is established by the outcome of the biological assays as per ISO 10993 standards.
    7. The sample size for the training set: Not applicable. This is not an AI/ML device.
    8. How the ground truth for the training set was established: Not applicable. This is not an AI/ML device.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1